LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

LLY

1,050.93

+2.96%↑

JNJ

248.43

+2.06%↑

ABBV

231.99

+3.33%↑

NVS

168.32

+1.89%↑

MRK

123.72

+3.77%↑

Strona główna・Stock List・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Closed

SectorHealthcare

28.47 -1.62

Buy Sell

Overview

Share price change

24h

Current

Min

28.38

Max

28.58

Key metrics
By Trading Economics
Income	11M 51M
Sales	39M 239M
P/E Sector Avg	8.476 108.767
EPS	1.08
Profit margin	21.242
Employees	268
EBITDA	14M 73M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+44.53% upside

Dividends
By Dow Jones
Next Earnings	5 maj 2026

Market Stats
By TradingEconomics
Market Cap	-140M 1.5B
Previous open	30.09
Previous close	28.47

Technical Score

By Trading Central

Confidence

Weak Bullish Evidence

29.8 / N/A Support & Resistance

Harmony Biosciences Holdings Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

1 mar 2026, 23:35 UTC

Major News Events

Oil Prices Jump in Asia as U.S.-Iran Conflict Stokes Supply Fears -- Energy Comment

1 mar 2026, 23:49 UTC

Market Talk

Major News Events

Australian Gold-Mining Stocks Rally as Attack on Iran Drives Gold Higher -- Market Talk

1 mar 2026, 23:47 UTC

Market Talk

Major News Events

Gold, Silver Rise as Middle East Conflict Spurs Safe-Haven Demand -- Market Talk

1 mar 2026, 23:41 UTC

Market Talk

Major News Events

Lasting Oil Price Shock Could Stoke Global Inflation -- Market Talk

1 mar 2026, 23:39 UTC

Market Talk

Major News Events

Global Equities Roundup: Market Talk

1 mar 2026, 23:39 UTC

Market Talk

Major News Events

Nikkei May Fall Amid Concerns About Higher Energy Prices -- Market Talk

1 mar 2026, 23:36 UTC

Market Talk

Major News Events

Oil Jumps as Middle East Conflict Heightens Supply Disruption Concerns -- Market Talk

1 mar 2026, 23:24 UTC

Market Talk

Global Energy Roundup: Market Talk

1 mar 2026, 23:24 UTC

Market Talk

Financial Markets Trim Bets on RBA Hike in May -- Market Talk

1 mar 2026, 23:21 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

1 mar 2026, 23:21 UTC

Market Talk

Sky Network TV's Risk/Reward Still Not Attractive -- Market Talk

1 mar 2026, 23:19 UTC

Major News Events

Front-Month Brent Crude Oil Futures Rose 8.5% to $79.08/bbl

1 mar 2026, 23:17 UTC

Major News Events

Front-Month WTI Crude Oil Futures Rose 8.4% to $72.65/bbl

1 mar 2026, 23:14 UTC

Major News Events

Front-Month WTI Crude Oil Futures Extend Gains in Early Trade

1 mar 2026, 22:55 UTC

Major News Events

Spot Gold Rises 1.9% to $5,278.61/oz Amid Middle East Conflict

1 mar 2026, 22:54 UTC

Major News Events

Front-Month WTI Crude Oil Futures Rise Amid Middle East Conflict

1 mar 2026, 22:53 UTC

Major News Events

Front-Month WTI Crude Oil Futures Rise 3.2% to $67.29/bbl

1 mar 2026, 22:38 UTC

Market Talk

Major News Events

Attack on Iran Likely to Push Up Floor Under Gold -- Market Talk

1 mar 2026, 22:21 UTC

Earnings

Berkshire's Earnings Weren't as Bad as They Looked. A Goodwill Write-Down Hit Operating Profits. -- Barrons.com

1 mar 2026, 22:17 UTC

Market Talk

Financial Markets Trim Bets On RBA Hike In May -- Market Talk

1 mar 2026, 22:13 UTC

Market Talk

Major News Events

OPEC+ Oil Output Boost Could Be Moot if Strait of Hormuz Unavailable -- Market Talk

1 mar 2026, 22:00 UTC

Market Talk

Major News Events

Oil Could Surge Above $100 If Flows Don't Return to Normal Quickly -- Market Talk

1 mar 2026, 21:40 UTC

Market Talk

Major News Events

Spot Gold Up as Investors Shield Against Risk -- Market Talk

1 mar 2026, 21:35 UTC

Market Talk

Major News Events

Oil Prices Seen Rising to Low to Mid-US$80s Per Barrel -- Market Talk

1 mar 2026, 21:30 UTC

Market Talk

Australian Dollar Weakens Most as Trader Fear Long-Term Conflict -- Market Talk

1 mar 2026, 21:27 UTC

Market Talk

Major News Events

Oil Prices Likely to Rise on Iran Conflict But to Manageable Levels -- Market Talk

1 mar 2026, 21:19 UTC

Market Talk

Major News Events

Shipping Disruptions 'More Acute Risk' Than Oil Output From Iran Conflict -- Market Talk

1 mar 2026, 20:58 UTC

Market Talk

Major News Events

Risk Off Stance in Markets Amid Fears of Wider Conflict -- Market Talk

1 mar 2026, 20:40 UTC

Market Talk

Australia Dollar to Fall Sharply Against U.S. Dollar on Middle East Conflict -- Market Talk

1 mar 2026, 20:24 UTC

Market Talk

Major News Events

Brent Crude at $100/bbl Could Slow Pace of Global Rate Cuts -- Market Talk

Peer Comparison

Price change

Harmony Biosciences Holdings Inc Forecast

Price Target

By TipRanks

44.53% upside

12 Months Forecast

Average 41.25 USD 44.53%

High 62 USD

Low 25 USD

Based on 8 Wall Street analysts offering 12 month price targets forHarmony Biosciences Holdings Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

8 ratings

Buy

Hold

Sell

Based on 8 analysts giving stock ratings to Harmony Biosciences Holdings Inc - Dist in the past 3 months.

Technical Score

By Trading Central

29.8 / N/ASupport & Resistance

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.